Mesoblast (MESO) Non-Current Assets (2015 - 2025)

Mesoblast (MESO) posted quarterly Non-Current Assets of $579.8 million for Q4 2025, down 0.65% year-on-year from $583.6 million in Q4 2024, and little changed on a QoQ basis from $580.3 million in Q2 2025.

Mesoblast (MESO) Non-Current Assets (2015 - 2025) Analysis & Trends

Mesoblast (MESO) has reported Non-Current Assets for 11 consecutive years, with $579.8 million the latest figure, recorded in Q4 2025.

  • Quarterly Non-Current Assets fell 0.65% year-over-year to $579.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $579.8 million (down 0.65% YoY) and the FY2025 annual result came in at $580.3 million, changed 0.4% from the prior year.
  • Non-Current Assets held at $579.8 million in Q4 2025 per MESO's latest filing, from $580.3 million in the prior quarter.
  • Over the last five years, Non-Current Assets for MESO reached as high as $596.5 million in Q2 2021 and fell as low as $579.8 million in Q4 2025.
  • A 5-year average of $589.3 million and a median of $589.9 million in 2022 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2021 — Non-Current Assets decreased 0.01% — and 2022, when it dropped 0.96%.
  • Year by year, Non-Current Assets stood at $595.6 million in 2021, then slipped by 0.96% to $589.9 million in 2022, then slipped by 0.81% to $585.1 million in 2023, then retreated by 0.25% to $583.6 million in 2024, then decreased by 0.65% to $579.8 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $579.8 million, $580.3 million, and $583.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Mesoblast 2.08 Bn 1.95 Bn - 579.82 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 579.82 Mn
Jun 30, 2025 580.33 Mn
Dec 31, 2024 583.64 Mn
Jun 30, 2024 582.69 Mn
Dec 31, 2023 585.13 Mn
Jun 30, 2023 587.76 Mn
Mar 31, 2023 589.08 Mn
Dec 31, 2022 589.93 Mn
Sep 30, 2022 591.54 Mn
Jun 30, 2022 592.31 Mn
Mar 31, 2022 593.56 Mn
Dec 31, 2021 595.64 Mn
Sep 30, 2021 595.60 Mn
Jun 30, 2021 596.49 Mn
Mar 31, 2021 596.36 Mn
Dec 31, 2020 596.85 Mn
Sep 30, 2020 596.84 Mn
Jun 30, 2020 597.05 Mn
Mar 31, 2020 596.40 Mn
Dec 31, 2019 596.93 Mn